Sunday 17 May 2020
myNEO will attend job fairs and participate in the following events provided that the Covid-19 regulations will allow for these events to take place:…
read more
Wednesday 7 April 2021
Fighting Cancer with Personalised Vaccines: ONCODNA and myNEO collaboration Read the recent press release here in Dutch, French or English. Onc…
Monday 22 March 2021
Join us at Innovation for Health (April 15-16)! Cedric Bogaert will give a presentation in the AI & Digital Health session (10.15am-11.15am) on how …
Thursday 11 March 2021
myNEO announced in May 2020 the identification of promising immunogenic covid-19 peptides by making smart use of its computational algorithms which r…
Tuesday 9 March 2021
myNEO was recently selected as one of the finalists of the Computable Awards 2021 Tech Startup of the Year award. Computable awards selected for t…
Sunday 17 January 2021
Ghent, Belgium, 4 November 2020 – myNEO, a developer of personalised therapeutics using the patient’s tumour-specific alterations, today announced th…
Tuesday 12 January 2021
Multiple reports have revealed that the original strains of SARS-CoV-2 have been divergently mutating into different sub-strains with different chara…
Monday 12 October 2020
myNEO has been selected as one of the five laureates for Belgian scale-up of the year (entrepreneurs on their way to an international breaktrough). …
Monday 7 September 2020
Cedric Bogaert will present the myNEO technology this week at the MedInvest – AI, Big Data and Digital Health conference. He will explain how AI can …
Monday 31 August 2020
myNEO recently affiliated with Amazon via the Amazon AWS activate program, that allows rapidly growing companies to further expand their MVP. This…
Thursday 2 July 2020
myNEO announces that promising Covid-19 peptides have been identified which will undergo further preclinical testing. By making smart use of existing…
Monday 18 May 2020
myNEO and eTheRNA announce a research programme to investigate a promising long non-coding RNA as a source of immunogenic targets for therapeutic use…
Monday 11 May 2020
myNEO collaborates with VUB-LMCT to develop high-throughput assays for immunogenicity validation of predicted SARS-CoV-2 epitopes The aim of the p…
Monday 4 May 2020
Over the last month, we’ve welcomed both Willem Stock, as a bioinformatician, Christophe Van Huffel, as busdev manager, and Bert Coessens, as technol…
Monday 27 April 2020
Despite the Covid-19 crisis, myNEO has been fully operational and has been focusing on the preparation for the clinical trial of Persomed later this …
Monday 20 April 2020
It’s long overdue, but we are proud to announce the launch of our new website! Not only does it provide a more responsive environment, but it also ca…
Sunday 5 April 2020
myNEO has evaluated whether symptom severity is related to immunogenicity across three different types of Corona viruses Many of us are wondering …
Wednesday 12 February 2020
Innovation for Health is the leading conference for key players in Health & Life Sciences. Innovation for Health is a great platform that brings expe…
Tuesday 28 January 2020
During the past few months, Flanders.Health has been working hard to support the VLAIO ICON call on personalised medicine and prepare for its possibl…
Monday 11 November 2019
The annual BIO-Europe event is the largest biotechnology partnering conference held in Europe. Over 4,000 global decision-makers from biotechnology, …